FDA
approval
· 2018-07-20
FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Original Application (NorthStar RxLLC)
Summary
The FDA approved a generic fixed-dose combination of sumatriptan and naproxen sodium for the acute treatment of migraine, under an original application by North…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SUMATRIPTAN AND NAPROXEN SODIUM (SUMATRIPTAN AND NAPROXEN SODIUM)